Dengue Testing

Dengue Testing

Global Dengue Testing Market to Reach $709.6 Million by 2027

Amid the COVID-19 crisis, the global market for Dengue Testing estimated at US$496.1 Million in the year 2020, is projected to reach a revised size of US$709.6 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. ELISA-Based Tests, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$353.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR Based Tests segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $134.4 Million, While China is Forecast to Grow at 8.1% CAGR

The Dengue Testing market in the U.S. is estimated at US$134.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$147.5 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Dengue IgG/IgM Rapid Test Segment to Record 4.6% CAGR

In the global Dengue IgG/IgM Rapid Test segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$44.4 Million in the year 2020 will reach a projected size of US$59.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$94.8 Million by the year 2027, while Latin America will expand at a 5.6% CAGR through the analysis period.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for ELISA-Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for RT-PCR Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Dengue IgG/IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Dengue IgG/IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Dengue IgG/IgM Rapid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 25: USA Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 28: USA Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 31: Canada Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: Canada Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: Canada 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 34: Canada Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 37: Japan Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Japan Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Japan 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 40: Japan Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Japan Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Japan 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 43: China Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: China Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: China 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 46: China Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: China Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: China 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
TABLE 49: Europe Current & Future Analysis for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 50: Europe Historic Review for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Europe 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 52: Europe Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Europe 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 55: Europe Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: Europe Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: Europe 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 58: France Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: France Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: France 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 61: France Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: France Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: France 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 64: Germany Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Germany Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Germany 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 67: Germany Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Germany Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Germany 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
TABLE 70: Italy Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Italy Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Italy 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 73: Italy Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: Italy Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Italy 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 76: UK Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: UK Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: UK 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 79: UK Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: UK Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: UK 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
SPAIN
TABLE 82: Spain Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Spain Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Spain 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 85: Spain Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Spain Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Spain 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
RUSSIA
TABLE 88: Russia Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Russia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Russia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 91: Russia Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Russia Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Russia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
TABLE 94: Rest of Europe Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Rest of Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Rest of Europe 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 97: Rest of Europe Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Rest of Europe Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Rest of Europe 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
TABLE 100: Asia-Pacific Current & Future Analysis for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 101: Asia-Pacific Historic Review for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Asia-Pacific 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
TABLE 103: Asia-Pacific Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: Asia-Pacific 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 106: Asia-Pacific Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: Asia-Pacific 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
AUSTRALIA
TABLE 109: Australia Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Australia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Australia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 112: Australia Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Australia Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Australia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
INDIA
TABLE 115: India Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: India Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: India 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 118: India Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: India Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: India 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
SOUTH KOREA
TABLE 121: South Korea Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: South Korea Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: South Korea 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 124: South Korea Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: South Korea Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: South Korea 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Rest of Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
LATIN AMERICA
TABLE 133: Latin America Current & Future Analysis for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 134: Latin America Historic Review for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Latin America 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
TABLE 136: Latin America Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Latin America 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 139: Latin America Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Latin America 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ARGENTINA
TABLE 142: Argentina Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Argentina Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Argentina 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 145: Argentina Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Argentina Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Argentina 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
BRAZIL
TABLE 148: Brazil Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Brazil Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Brazil 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 151: Brazil Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Brazil Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Brazil 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
MEXICO
TABLE 154: Mexico Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Mexico Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Mexico 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 157: Mexico Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Mexico Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Mexico 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
TABLE 160: Rest of Latin America Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: Rest of Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: Rest of Latin America 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 163: Rest of Latin America Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: Rest of Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: Rest of Latin America 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
MIDDLE EAST
TABLE 166: Middle East Current & Future Analysis for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 167: Middle East Historic Review for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: Middle East 15-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
TABLE 169: Middle East Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: Middle East 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 172: Middle East Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: Middle East 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
IRAN
TABLE 175: Iran Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Iran Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Iran 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 178: Iran Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Iran Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Iran 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ISRAEL
TABLE 181: Israel Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Israel Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Israel 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 184: Israel Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Israel Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Israel 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
SAUDI ARABIA
TABLE 187: Saudi Arabia Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Saudi Arabia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Saudi Arabia 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 190: Saudi Arabia Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Saudi Arabia Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Saudi Arabia 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
TABLE 193: UAE Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: UAE Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: UAE 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 196: UAE Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: UAE Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: UAE 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
TABLE 199: Rest of Middle East Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Rest of Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Rest of Middle East 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 202: Rest of Middle East Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Rest of Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Rest of Middle East 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
AFRICA
TABLE 205: Africa Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Africa Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Africa 15-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG/IgM Rapid Test for the Years 2012, 2020 & 2027
TABLE 208: Africa Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Africa Historic Review for Dengue Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Africa 15-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 41

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook